Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway.

Tripathi SC, Fahrmann JF, Celiktas M, Aguilar M, Marini KD, Jolly MK, Katayama H, Wang H, Murage EN, Dennison JB, Watkins DN, Levine H, Ostrin EJ, Taguchi A, Hanash SM.

Cancer Res. 2017 Aug 15;77(16):4414-4425. doi: 10.1158/0008-5472.CAN-16-2874. Epub 2017 Jun 23.

2.

PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue.

Gao H, Niu G, Yang M, Quan Q, Ma Y, Murage EN, Ahn JM, Kiesewetter DO, Chen X.

Mol Pharm. 2011 Oct 3;8(5):1775-82. doi: 10.1021/mp200141x. Epub 2011 Aug 19.

3.

Development of potent glucagon-like peptide-1 agonists with high enzyme stability via introduction of multiple lactam bridges.

Murage EN, Gao G, Bisello A, Ahn JM.

J Med Chem. 2010 Sep 9;53(17):6412-20. doi: 10.1021/jm100602m.

PMID:
20687610
4.

Search for alpha-helical propensity in the receptor-bound conformation of glucagon-like peptide-1.

Murage EN, Schroeder JC, Beinborn M, Ahn JM.

Bioorg Med Chem. 2008 Dec 1;16(23):10106-12. doi: 10.1016/j.bmc.2008.10.006. Epub 2008 Oct 5.

PMID:
18952440

Supplemental Content

Loading ...
Support Center